Ursodeoxycholic Acid Treatment of Cholesterol Gallstone Disease

References

• Barbara L, Sama C, Labate A MM, Taroni F, Rusticali A G, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1983; 7: 913–7
   Google Scholar
• The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Prevalence of gallstones in an adult female population. Am J Epidemiol 1984; 119: 796–805
   PubMed Web of Science ®Google Scholar
• The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. I. Prevalence data in men. Hepatology 1988; 8: 904–6
   PubMed Web of Science ®Google Scholar
• Jorgenson T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987; 126: 912–21
   PubMedGoogle Scholar
• Glambek I, Kvaale G, Arnesjo B, Soreide O. Prevalence of gallstones in a Norwegian population. Scand J Gastroenterol 1987; 22: 1087–94
   Google Scholar
• Dubois F, Berthelot G, Levard H. Cholecystectomie par coelioscopie. Presse Med 1989; 18: 980–2
   PubMed Web of Science ®Google Scholar
• Perissat J, Collet D, Belliard R. Gallstones: laparoscopic treatment, intracorporeal lithotripsy followed by cholecystostomy and cholecystectomy–a personal experience. Endoscopy 1989; 21: 373–4
   PubMedGoogle Scholar
• Roddick E J, Olsen D O. Laparoscopic laser cholecystectomy. Surg Endosc 1989; 3: 131–3
   PubMedGoogle Scholar
• The Southern Surgeons' Club. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 1991; 324: 1073–8
   PubMedGoogle Scholar
• Schiff M. Il coleinato di soda nella cura dei calcoli biliari. L'Imparziale 1873; 13: 97–9
   Google Scholar
• Dabney WC. The use of cholate of soda to prevent the formation of gallstones. Am J Med Sci 1876; 71: 410
   Google Scholar
• Rewbridge AG. The disappearance of gallstone shadows following the prolonged administration of bile salts. Surgery 1937; 1: 395–400
   Google Scholar
• Danzinger R G, Hofmann A F, Schoenfield L S, Thistle J L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286: 1–8
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Makino I, Ishizaki T, et al. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1977; ii: 367–9
   Google Scholar
• Paumgartner G, Sauerbruch T. Gallstones: pathogenesis. Lancet 1991; 338: 1117–24
   PubMed Web of Science ®Google Scholar
• Salen G, Tint G S, Shefer S. Treatment of cholesterol gallstones with litholytic bile acids. Gastroenterology Clin North Am 1991; 20: 171–82
   PubMedGoogle Scholar
• Hofmann AF. Medical treatment of cholesterol gallstones by bile desaturating agents. Hepatology 1984; 4: 199S–208S
   PubMedGoogle Scholar
• Salen G, Nikolau G, Shefer S. Chenodeoxycholic acid (CDCA) inhibits elevated HMG-CoA reductase activity in subjects with gallstones. Clin Res 1973; 21: 523
   Google Scholar
• Ahlberg J, Angelin B, Einarsson K. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic and chenodeoxycholic acid treatment. J Lipid Res 1981; 22: 410–22
   PubMed Web of Science ®Google Scholar
• Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Gastroenterology 1983; 85: 1248–56
   PubMed Web of Science ®Google Scholar
• May G R, Shaffer E A, Sutherland L R. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther 1993; 7: 139–48
   PubMedGoogle Scholar
• Senior J R, Johnson M F, DeTurck D M, Bazzoli F, Roda E. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids. Gastroenterology 1990; 99: 243–51
   PubMed Web of Science ®Google Scholar
• Fromm H, Roat J W, Gonzalez V, Sarva R P, Farivar S. Comparative efficacy and side effects of ursodeoxycholic acid and chenodeoxycholic acid in dissolving gallstones. A Double-blind controlled study. Gastroenterology 1983; 85: 1257–64
   PubMed Web of Science ®Google Scholar
• Podda M, Zuin M, Battezzati P M, Ghezzi C, DeFazio C, Dioguardi M L. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology 1989; 96: 222–9
   PubMed Web of Science ®Google Scholar
• Roehrkasse R, Fromm H, Malavolti M, Tunuguntla A K, Ceryak S. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool and serum lipids. Dig Dis Sci 1986; 31: 1032–40
   PubMedGoogle Scholar
• Walters J RF, Hood K A, Gleeson D, Ellul P M, Keightley A, Murphy G M, et al. Combination therapy with oral ursodeoxycholic acid and chenodeoxycholic acids: pretreatment computed tomography of the gallbladder improves gallstone dissolution efficacy. Gut 1992; 33: 375–80
   PubMedGoogle Scholar
• Lanzini A, Facchinetti D, Northfield T C. Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration. Gastroenterology 1988; 95: 1029–35
   PubMedGoogle Scholar
• Bateson M C, Bouchier I AD, Trash D B, Maugdal D P, North-field T C. Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br Med J 1981; 283: 645–6
   PubMed Web of Science ®Google Scholar
• Neubrand M, Sauerbruch T, Stellaard F, Paumgartner G. In vitro cholesterol gallstone dissolution after fragmentation with shock waves. Digestion 1986; 34: 51–9
   PubMedGoogle Scholar
• Sackmann M, Pauletzki J, Sauerbruch T, Holl J, Schelling G, Paumgartner G. The Munich gallbladder lithotripsy study: results of the first 5 years with 711 patients. Ann Intern Med 1991; 114: 290–6
   PubMed Web of Science ®Google Scholar
• Sackmann M, Pauletzki J, Delius M, Holl J, Sauerbruch T, Paumgartner G. Non-invasive therapy of gallbladder calculi with a radiopaque rim. Gastroenterology 1992; 102: 988–93
   PubMedGoogle Scholar
• Tint G S, Dryszka H, Sanghavi B, Patel G, Patel S, Shefer S, et al. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones. Gastroenterology 1992; 102: 2042–9
   PubMedGoogle Scholar
• Sackmann M, Pauletzki J, Aydernir U, Holl J, Sauerbruch T, Hasford J, et al. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with a combination of ursodeoxycholic acid and chenodeoxycholic acid. Hepatology 1991; 14: 1136–41
   PubMedGoogle Scholar
• Fisher R S, Stelzer F, Rock E, Malmud L S. Abnormal gallbladder emptying in patients with gallstones. Dig Dis Sci 1982; 27: 1019–24
   PubMed Web of Science ®Google Scholar
• Pomeranz I, Shaffer E A. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88: 787–91
   PubMed Web of Science ®Google Scholar
• Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, et al. Gallbladder motility in cholesterol gallstone dissolution. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990; 99: 1779–85
   PubMed Web of Science ®Google Scholar
• Pauletzki J, Sailer C, Klüppelberg U, Neubrand M, von Ritter C, Holl J, et al. Gallbladder emptying is a determinant of gallstone clearance after lithotripsy. Gastroenterology 1993; 104: A375
   Google Scholar
• Sackmann M, Eder H, Spengler U, Pauletzki J, Holl J, Paumgartner G, et al. Gallbladder emptying is an important factor in fragment disappearance after shock-wave lithotripsy. J Hepatol 1993; 17: 62–6
   PubMed Web of Science ®Google Scholar
• Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 1989; 97: 726–31
   PubMed Web of Science ®Google Scholar
• Petroni M L, Jazrawi R P, Goggin P M, Lanzini A, Facchinetti D, Heaton K W, et al. Characteristics of recurrent gallstones following non-surgical treatment: implications for retreatment. Eur J Gastroenterol Hepatol 1991; 3: 473–8
   Google Scholar
• Sackmann M, Niller H, Klueppelberg U, von Ritter C, Pauletzki J, Holl J, et al. Gallstone recurrence after shock wave therapy. Gastroenterology 1994; 106: 225–30
   PubMedGoogle Scholar
• Berr F, Mayer M, Sackmann M, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994; 106: 215–24
   PubMedGoogle Scholar